Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

NDORMS, with the Botnar Research Institute and Kennedy Institute of Rheumatology, has been designated a EULAR Centre of Excellence in Rheumatology 2015-2020, in recognition of our continued high-quality research publications in rheumatology.

EULAR, the European League Against Rheumatism, represents patients, health professionals and scientific societies of rheumatology of all European nations. It aims to reduce the burden of rheumatic diseases on the individual and society and to improve the treatment, prevention and rehabilitation of musculoskeletal diseases.

Its Centres of Excellence are top rheumatology research units in Europe aiming to develop a group of first-class research centres for active researchers and enable exchange of fellows and research projects.

NDORMS is one of the largest and most dynamic multidisciplinary academic rheumatology research centres in the world, with over 50 dedicated researchers focusing on rheumatic conditions.

We have one of the largest and broadest groupings of translational rheumatology research in the world; covering inflammatory, degenerative and congenital diseases of the musculoskeletal system. Scientific approaches include direct patient-focused research, epidemiology, and basic mechanistic research in immunology, genetics, bone, matrix and cartilage biology.

Professor Paul Bowness, who led on the department's application, assisted by Professor Richard Williams from the Kennedy Institute said: "We are delighted with this award and the recognition it brings to NDORMS for its research into diverse rheumatic conditions and important rheumatology research is for the lives of millions of people around the world. This supports our mission to develop and deliver excellent clinical and basic research and foster collaborations with other Centres of Excellence."

Similar stories

New centre aims to help companies conduct more efficient trials

Botnar Main Trials

A new clinical therapeutics centre has been set up by the University of Oxford to help life sciences companies identify interventions that have the greatest potential to deliver patient benefit, and so bring down the cost of early phase clinical trials.

Cognitive–behavioural therapy consistently improves quality of life

Main Rehabilitation and self-management Research

A meta-review of the available research into cognitive behavioural therapy reveals it consistently improves health-related quality of life across different medical conditions and demographic populations.

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Main Research

The University of Oxford has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Versus Arthritis Foundation Fellowship awarded to Dr Kristina Zec

Awards Main

Dr Kristina Zec has been awarded a Versus Arthritis Foundation Fellowship to investigate the role of products of lipid oxidation produced by synovial macrophages in triggering articular inflammation.

Study reveals the safety of bisphosphonates in chronic kidney disease

Main

The results of an observational study published in JMBR and funded by the Health Technology Assessment Programme shows that bisphosphonate use is associated with a greater risk of chronic kidney disease progression.

WHiTE Four trial results published

Hip Main OCTRU Orthopaedics and trauma Research

The results of the WHiTE Four clinical trial for the treatment of fragility hip fractures have been published in The Bone and Joint Journal.